Search Results - "Skupa, Sydney A"
-
1
Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies
Published in International journal of molecular sciences (24-01-2023)“…The gut microbiome is increasingly being recognized as an important immunologic environment, with direct links to the host immune system. The scale of the gut…”
Get full text
Journal Article -
2
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Published in International journal of molecular sciences (16-06-2022)“…B-cell chronic lymphocytic leukemia (CLL) results from intrinsic genetic defects and complex microenvironment stimuli that fuel CLL cell growth through an…”
Get full text
Journal Article -
3
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Published in Hemato (01-09-2024)“…B-cell receptor (BCR) signaling is a central driver in chronic lymphocytic leukemia (CLL), along with the activation of pro-survival pathways (e.g., NF-κB) and…”
Get full text
Journal Article -
4
Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia
Published in Leukemia & lymphoma (27-09-2024)“…Chronic lymphocytic leukemia (CLL) remains incurable and its ability to acquire resistance to front-line therapeutics has proved challenging. Bromodomain and…”
Get full text
Journal Article -
5
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
Published in Cancer research communications (22-05-2024)“…Chronic lymphocytic leukemia (CLL) cell survival and growth is fueled by the induction of B-cell receptor (BCR) signaling within the tumor microenvironment…”
Get full text
Journal Article -
6
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia
Published in JCI insight (22-05-2024)“…Redundant tumor microenvironment (TME) immunosuppressive mechanisms and epigenetic maintenance of terminal T cell exhaustion greatly hinder functional…”
Get full text
Journal Article -
7
Comparison of Dietary Intake and Dietary Inflammatory Index in Patients with Chronic Lymphocytic Leukemia By Treatment Status to Cohabitating Controls
Published in Blood (02-11-2023)“…Chronic lymphocytic leukemia (CLL) is an incurable disease with a varied presentation ranging from indolent and asymptomatic to morbid and life-limiting. As…”
Get full text
Journal Article -
8
A Novel Spirocyclic Dimer (SpiD3) Resensitizes CLL Cells to Venetoclax
Published in Blood (15-11-2022)Get full text
Journal Article -
9
Progressive Gut Microbiome Dysbiosis Is Associated with Chronic Lymphocytic Leukemia Pathogenesis and Development in the Eµ-TCL1 Mouse Model
Published in Blood (02-11-2023)“…Introduction: The gut microbiome is home to a community of microorganisms such as bacteria, fungi, viruses, archaea, and protozoa. Maintaining a balance…”
Get full text
Journal Article -
10
BET Inhibition As a Targeted Epigenetic Approach to Reverse T Cell Dysfunction in Chronic Lymphocytic Leukemia
Published in Blood (23-11-2021)“…Introduction: Chronic Lymphocytic Leukemia (CLL) is characterized by the clonal expansion of mature CD19+/CD5+ lymphocytes in the peripheral blood and…”
Get full text
Journal Article -
11
Abstract 6396: BET inhibition alleviates T-cell dysfunction in chronic lymphocytic leukemia
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Background: The chronic lymphocytic leukemia (CLL) tumor microenvironment (TME) is laden with hyporesponsive T-cells that permit disease persistence…”
Get full text
Journal Article